D. Nixon

发表

Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost

R. Fechtner, D. Hollander, P. Harasymowycz, 2011, Clinical ophthalmology.

Three-month, randomized, parallel-group comparison of brimonidine–timolol versus dorzolamide–timolol fixed-combination therapy*

J. Chartrand, D. Yan, D. Hollander, 2009, Current medical research and opinion.

Early Canadian Real-World Experience with Brolucizumab in Anti-Vascular Endothelial Growth Factor-Experienced Patients with Neovascular Age-Related Macular Degeneration: A Retrospective Chart Review

J. Noble, M. Giunta, D. Nixon, 2022, Clinical ophthalmology.

OPTH_A_376199 2885..2894

J. Noble, M. Giunta, D. Nixon, 2022 .

Microincisions in cataract surgery.

T. Raviv, S. Dewey, G. Beiko, 2014, Journal of cataract and refractive surgery.

Software-based evaluation of toric IOL orientation in a multicenter clinical study.

S. Kasthurirangan, Pamela J Smith, D. Nixon, 2014, Journal of refractive surgery.

Evaluation of contrast sensitivity and other visual function outcomes in diabetic macular edema patients following treatment switch to aflibercept from ranibizumab

N. Flinn, D. Nixon, 2018, Clinical ophthalmology.

Preoperative cataract grading by Scheimpflug imaging and effect on operative fluidics and phacoemulsification energy

D. Nixon, 2010, Journal of cataract and refractive surgery.

Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)

Dawn Y. Lim, John C. Greiner, H. Thieme, 2021, Drugs.

An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian Lumigan® RC Early Analysis Review (CLEAR) trial

C. Hutnik, A. Crichton, C. Sigouin, 2014, Clinical ophthalmology.

An observational study of bimatoprost 0.01% in treatment-naïve patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial

C. Hutnik, A. Crichton, C. Sigouin, 2012, Clinical ophthalmology.

Contrast Sensitivity Changes in Center Involving Diabetic Macular Edema Treated with Aflibercept

N. Flinn, D. Nixon, Claudia Enderlein, 2021, Clinical ophthalmology.

Visual Function for Driving in Diabetic Macular Edema and Retinal Vein Occlusion Post-Stabilization with Anti-Vascular Endothelial Growth Factor

N. Flinn, D. Nixon, 2021, Clinical ophthalmology.

OPTH_A_338478 4439..4445

N. Flinn, D. Nixon, Claudia Enderlein, 2021 .

A randomized, prospective study of bimatoprost 0.01% or travoprost/timolol in patients previously treated with latanoprost and timolol to reduce intraocular pressure.

D. Nixon, 2013, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Reply: To PMID 25135548.

T. Raviv, S. Dewey, G. Beiko, 2015, Journal of cataract and refractive surgery.

Evaluation of contrast sensitivity and other visual function outcomes in neovascular age-related macular degeneration patients after treatment switch to aflibercept from ranibizumab

N. Flinn, D. Nixon, 2017, Clinical ophthalmology.

In vivo digital imaging of the square‐edged barrier effect of a silicone intraocular lens

D. Nixon, 2004, Journal of cataract and refractive surgery.

Clinical Ophthalmology Dovepress

R. Fechtner, D. Hollander, P. Harasymowycz, 2022 .

Three-month, randomized, parallel-group comparison of brimonidine–timolol versus dorzolamide–timolol fixed-combination therapy*

J. Chartrand, D. Yan, D. Hollander, 2009, Current medical research and opinion.

Evaluation of contrast sensitivity and other visual function outcomes in neovascular age-related macular degeneration patients after treatment switch to aflibercept from ranibizumab

N. Flinn, D. Nixon, 2017, Clinical ophthalmology.

Evaluation of lens epithelial cell migration in vivo at the haptic-optic junction of a one-piece hydrophobic acrylic intraocular lens.

D. Apple, D. Nixon, 2006, American journal of ophthalmology.